CHRW
76
-3
MDT
53
-2
NEE
54
2
MHK
52
2
AKAM
59
-2
MCHP
43
-6
OXY
38
-2
KLAC
72
-2
CMA
67
2
BDX
61
2
V
52
-2
L
69
-3
RCL
61
-5
IP
39
5
CPB
39
2
CNP
57
3
ZTS
27
2
LEG
57
4
VZ
42
3
ETN
57
-3
CHRW
76
-3
MDT
53
-2
NEE
54
2
MHK
52
2
AKAM
59
-2
MCHP
43
-6
OXY
38
-2
KLAC
72
-2
CMA
67
2
BDX
61
2
V
52
-2
L
69
-3
RCL
61
-5
IP
39
5
CPB
39
2
CNP
57
3
ZTS
27
2
LEG
57
4
VZ
42
3
ETN
57
-3
Financhill
Back

iShares iBonds Dec 2031 Term Corporate ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Buy
55

IBDW
iShares iBonds Dec 2031 Term Corporate ETF

Last Price:
$21.20
Seasonality Move:
-5%
Buy
57

LYEL
Lyell Immunopharma, Inc.

Last Price:
$36.08
Seasonality Move:
-22.7%
Buy
55
iShares iBonds Dec 2031 Term Corporate ETF (IBDW) is a Buy

Is iShares iBonds Dec 2031 Term Corporate ETF a Buy, Sell or Hold?

  • The current iShares iBonds Dec 2031 Term Corporate ETF [IBDW] share price is $21.17. The Score for IBDW is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • IBDW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $35.09. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IBDW Stock Price Chart

What is iShares iBonds Dec 2031 Term Corporate ETF's stock price today?

  • The iShares iBonds Dec 2031 Term Corporate ETF share price today is $21.17
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBDW is experiencing slight buying pressure.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $35.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight buying pressure.

IBDW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 50.71 Buy
Chaikin Money Flow: -292622 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.23 Buy
Relative Strength Index (14 RSI): 66.16 Buy
Chaikin Money Flow: -92149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

IBDW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.16 Buy
20-day SMA: 21.17 Sell
50-day SMA: 21.2 Sell
200-day SMA: 20.94 Buy
8-day EMA: 21.15 Buy
20-day EMA: 21.16 Buy
50-day EMA: 20.85 Buy
200-day EMA: 13.69 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.85 Buy
20-day SMA: 30.4 Buy
50-day SMA: 22.87 Buy
200-day SMA: 13.87 Buy
8-day EMA: 35.03 Buy
20-day EMA: 31.05 Buy
50-day EMA: 24.98 Buy
200-day EMA: 18 Buy

iShares iBonds Dec 2031 Term Corporate ETF Earnings Growth & IBDW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

iShares iBonds Dec 2031 Term Corporate ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):